United StatesMethylergonovine Maleate Tablets, USP 0.2 mg, packaged as 20 tablets (2 x 10) with carton label “MAJOR” and blister label “Methylergonovine Maleate Tablets, 0.2 mg, USP, One Tablet, Major Pharm/Indianapolis, IN 46268,” NDC 0904-7282-10 (lots N02327 exp. 09/2026; N02740 exp. 12/2026; N03069 exp. 08/2027) are being recalled. The Harvard Drug Group LLC is recalling 790 cartons nationwide because the drug is subpotent.
What's being recalled
Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, in 46268, NDC 0904-7282-10. Blister Label: Methylergonovine Maleate Tablets, 0.2 mg, USP, One Tablet, Major Pharm/Indianapolis, IN 46268, NDC 0904-7282-10.
Recalling firm: The Harvard Drug Group LLC, Dublin, OH, United States.
How to identify it
Lots: N02327, expires: 09/2026; N02740, expires: 12/2026; N03069, expires: 08/2027.
The hazard
Subpotent Drug
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
U.S. Nationwide.
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)